Literature DB >> 19251951

Adipokines and the clinical laboratory: what to measure, when and how?

M J Hill1, S Kumar, P G McTernan.   

Abstract

This review summarises current experimental adipokine investigations and will focus on some of the procedures and techniques that are currently important in the clinical research laboratory. The complexity of measuring adipokines is discussed and the relative success of the various applications in the transition from the laboratory to clinical diagnosis assessed. In addition, as new adipokines continue to emerge, this review will consider the direction research is taking at the cutting edge of novel adipokine discovery. Finally, how a more comprehensive understanding of the pathobiology related to adipokines may enhance innovative therapeutic strategies designed to attenuate the predicted explosion in obesity related diseases will be discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19251951     DOI: 10.1136/jcp.2007.049171

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  5 in total

1.  Plasma Leptin and Reduced FEV1 and FVC in Chronic Spinal Cord Injury.

Authors:  Eric Garshick; Palak Walia; Rebekah L Goldstein; Merilee Teylan; Antonio A Lazzari; Carlos G Tun; Jaime E Hart
Journal:  PM R       Date:  2017-08-19       Impact factor: 2.298

2.  Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women?

Authors:  Mia M Gaudet; Roni T Falk; Gretchen L Gierach; James V Lacey; Barry I Graubard; Joanne F Dorgan; Louise A Brinton
Journal:  Cancer Epidemiol       Date:  2010-06-26       Impact factor: 2.984

3.  Adiponectin is inversely associated with intramyocellular and intrahepatic lipids in obese premenopausal women.

Authors:  Miriam A Bredella; Martin Torriani; Reza H Ghomi; Bijoy J Thomas; Danielle J Brick; Anu V Gerweck; Lindsey M Harrington; Karen K Miller
Journal:  Obesity (Silver Spring)       Date:  2010-12-09       Impact factor: 5.002

Review 4.  Adiponectin and polycystic ovary syndrome.

Authors:  Susan W Groth
Journal:  Biol Res Nurs       Date:  2010-05-24       Impact factor: 2.522

5.  Correlation between measures of insulin resistance in fasting and non-fasting blood.

Authors:  Robert J Hancox; C Erik Landhuis
Journal:  Diabetol Metab Syndr       Date:  2011-09-07       Impact factor: 3.320

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.